The Buck Institute pioneers research on aging and disease pacificsun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pacificsun.com Daily Mail and Mail on Sunday newspapers.
Two studies are part of a growing body of research focusing on ketones as possible preventative and treatment options for a range of conditions, including for mental illness, cancer and dementia.
UConn Joins Landmark Trial of Ketogenic Supplements for Aging miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The NIH has funded the first trial of ketone supplements in the elderly to investigate their potential impact on a broad range of measures that affect strength, cognition, and activities of daily living.
The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.